Year: 2024

CORRECTION — North Dallas Bank & Trust Co. Announces Third Quarter Earnings

Written by Customer Service on October 25, 2024. Posted in Earnings Releases And Operating Results.

In a release issued earlier today under the same headline by North Dallas Bank & Trust Co., (OTC: NODB) please note that the word “Second” in the headline should instead read “Third”. The release follows: DALLAS, Oct. 25, 2024 (GLOBE NEWSWIRE) — NDBT (North Dallas Bank & Trust Co.), an independent community bank established in 1961, today announced net earnings for three months of $502,493 or $0.20 per share, and net earnings for nine months of $2,186,955 or $0.85 per share, for the periods ending September 30, 2024. Earnings were prepared internally without review by the company’s independent accountants. Financial results are the results of past performance, events and market conditions, and are not a guarantee for future results. Any forward-looking implications derived from this information...

Bank of the James Announces Third Quarter, First Nine Months of 2024 Financial Results and Declaration of Dividend

Written by Customer Service on October 25, 2024. Posted in Earnings Releases And Operating Results.

Year-Over-Year Loan Growth, Deposit Expansion, High Asset Quality LYNCHBURG, Va., Oct. 25, 2024 (GLOBE NEWSWIRE) — Bank of the James Financial Group, Inc. (the “Company”) (NASDAQ:BOTJ), the parent company of Bank of the James (the “Bank”), a full-service commercial and retail bank, and Pettyjohn, Wood & White, Inc. (“PWW”), an SEC-registered investment advisor, today announced unaudited results of operations for the three month and nine month periods ended September 30, 2024. The Bank serves Region 2000 (the greater Lynchburg MSA) and the Blacksburg, Buchanan, Charlottesville, Harrisonburg, Lexington, Nellysford, Roanoke, and Wytheville, Virginia markets. Net income for the three months ended September 30, 2024 was $1.99 million or $0.44 per basic and diluted share compared with $2.08 million or $0.46 per basic and diluted...

Federal Home Loan Bank of Des Moines Announces Third Quarter 2024 Financial Results, Declares Dividend

Written by Customer Service on October 25, 2024. Posted in Earnings Releases And Operating Results.

DES MOINES, Iowa, Oct. 25, 2024 (GLOBE NEWSWIRE) — Third Quarter 2024 HighlightsNet income of $204 million Voluntary community and housing contributions of $40 million Affordable Housing Program (AHP) assessments of $23 million Advances totaled $98.9 billion Mortgage loans held for portfolio, net totaled $11.4 billion Letters of credit totaled $18.2 billion Retained earnings totaled $3.4 billionDividend The Board of Directors approved a third quarter 2024 dividend to be paid at an annualized rate of 9.50 percent on average activity-based stock, and 6.00 percent on average membership stock, unchanged from the prior quarter. The Federal Home Loan Bank of Des Moines (the Bank) expects to make dividend payments totaling $137 million on November 13, 2024. Affordable Housing and Community Impact The Bank’s housing and community...

Success of the Offer

Written by Customer Service on October 25, 2024. Posted in Mergers And Acquisitions.

PRESS RELEASE Ivry-sur-Seine, France — October 25, 2024, 18:30 p.m. CEST THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT PERMITTED IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER COUNTRY WHERE SUCH COMMUNICATION WOULD VIOLATE THE RELEVANT APPLICABLE REGULATION END OF THE OFFER PERIOD FOR THE VOLUNTARY MIXED PUBLIC TENDER OFFER FOR THE CAPITAL OF UNIEURO FNAC DARTY AND RUBY WELCOME THE TENDERING OF A LARGE MAJORITY OF UNIEURO’S SHARE CAPITAL PAVING THE WAY TOWARDS A FRUITFUL INDUSTRIAL PARTNERSHIPPreliminary results of the Offer: 67,1% of Unieuro’s share capital tendered, which cumulated to the 4.4% already owned by Fnac Darty, represent 71,5% of Unieuro’s share capital Fulfillment of the Minimum Threshold Condition Reopening of the Tender...

Korjaus pörssitiedotteeseen: QPR Software Oyj:n taloudellinen raportointi vuonna 2025

Written by Customer Service on October 25, 2024. Posted in Public Companies.

QPR SOFTWARE OYJ PÖRSSITIEDOTE 25.10.2024 klo 19.00Korjaus pörssitiedotteeseen: QPR Software Oyj julkaisi tänään tiedotteen vuoden 2025 taloudellisesta kalenterista, jossa esitettiin taloudellisten raporttien suunnitellut julkaisupäivät. Suomenkielisessä tiedotteessa oli virhe vuosikertomuksen julkaisupäivän vuosiluvussa, mutta englanninkielinen tiedote sisälsi oikean päivämäärän. Alla on suomenkielinen tiedote korjattuna oikealla päivämäärällä.Tässä pörssitiedotteessa QPR Software Oyj esittää taloudellisen kalenterin vuodelle 2025, joka sisältää taloudellisten raporttien suunnitellut julkaisupäivät. QPR julkaisee vuonna 2025 kolme osavuosikatsausta:Osavuosikatsaus tammi–maaliskuu 2025 torstaina 24.4.2025 Puolivuosikatsaus tammi-kesäkuu 2025 perjantaina 18.7.2025 Osavuosikatsaus...

Credit Agricole Nord de France – Resultats Financiers au 30 Septembre 2024

Written by Customer Service on October 25, 2024. Posted in Earnings Releases And Operating Results.

Lille, le 25 octobre 2024 Résultats financiers au 30 Septembre 2024 du Crédit Agricole Mutuel Nord de France Septembre 2024 Septembre 2023 Variation Activité : Encours de collecte globale 38 188 M€ 37 110 M€ 2,90%Encours de crédit 28 749 M€ 28 862 M€ -0,39% Résultats sociaux* : Produit Net Bancaire 494,2 M€ 455,6 M€ 8,47%Résultat Brut d’Exploitation 206,9 M€ 158,7 M€ 30,38%Résultat Net 126,7 M€ 114,7 M€ 10,45% Résultats consolidés IFRS : Produit Net Bancaire 545,8 M€ 495,8 M€ 10,08%Résultat Brut d’Exploitation 226,8 M€ 162,4 M€ 39,66%Résultat Net Part du Groupe 157,7 M€ 129,1 M€ 22,18% Structure financière : Bilan consolidé 38 221 M€ 38 273 M€** -0,14%Ratio CET1 Bâle 3 28,37%*** 29,05% -0,68...

GTT: Nine-month 2024 revenues stand at 465 million euros, up 55%; good order momentum continues

Written by Customer Service on October 25, 2024. Posted in Earnings Releases And Operating Results.

Nine-month 2024 revenues stand at 465 million euros, up 55%; good order momentum continues9M 2024 revenues: 464.7 million euros, +54.9% compared to 9M 2023 Sustained order level: 68 LNG carriers, 12 ethane carriers, 1 FSRU, 1 FLNG, 12 LNG-powered container ships and 1 LNG bunker vessel 2024 objectives: revenues and EBITDA expected to be at the top of the rangesParis – October 25, 2024. GTT, the technological expert in membrane containment systems used to transport and store liquefied gases, today announces its revenues for the first nine months of 2024. Commenting on the results, Jean-Baptiste Choimet, Chief Executive Officer of GTT, said: “With a total of 68 LNG carrier orders, 12 ethane carrier orders, one regasification unit order and one FLNG unit order, the commercial performance of our core business was particularly strong...

Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections

Written by Customer Service on October 25, 2024. Posted in Public Companies.

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades –Company to Host Conference Call on Monday, October 28th at 8:30 a.m. EDT– DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug Administration (FDA) has approved Iterum’s new drug application for ORLYNVAH™ (sulopenem etzadroxil and probenecid) for the treatment of uncomplicated urinary tract infections (uUTIs) caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women who have limited or no alternative oral antibacterial treatment options. This is the first approved indication for ORLYNVAH™ and the first FDA-approved...

Ultimovacs Announces Publication of Phase II FOCUS Trial Results on medRxiv

Written by Customer Service on October 25, 2024. Posted in Public Companies.

Oslo, October 25, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announced that the results from Phase II FOCUS trial (NCT05075122) have been published online on the preprint platform medRxiv. As previously reported, topline data readout demonstrated that adding UV1 to the standard of care pembrolizumab did not lead to clinical benefits in progression free survival or overall survival in the late-stage head and neck squamous cell carcinoma (HNSCC) patients recruited in the study. The study therefore did not meet its primary and secondary endpoints. UV1 continued to demonstrate a positive safety profile in line with other UV1 studies with similar events observed in the control arm and good tolerability. ==ENDS== About FOCUSThe FOCUS trial (First-line...

NewtekOne, Inc. CEO, Barry Sloane, to Present at the LD Micro Main Event XVII on October 29, 2024

Written by Customer Service on October 25, 2024. Posted in Public Companies.

BOCA RATON, Fla., Oct. 25, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (NASDAQ: NEWT) announced today that NewtekOne’s CEO and President, Barry Sloane, will present at the LD Micro Main Event XVII on Tuesday, October 29, 2024 at 11:00AM ET (8:00AM PT), Track 1, at the Luxe Sunset Blvd Hotel in Los Angeles, CA. Mr. Sloane will hold one-on-one meetings on October 29-30, 2024. To schedule a meeting, please contact your LD Micro representative, or Jayne Cavuoto, Director of Investor Relations at NewtekOne at jcavuoto@newtekone.com. A real-time webcast of Mr. Sloane’s presentation at the LD Micro conference will be available at the start of his presentation at 11:00AM ET (8:00AM PT) in the ‘Events & Presentations’ section of the Investor Relations portion of NewtekOne’s website at LD Micro Main Event XVII Presentation. A replay of...

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals